B.M.P. Pharma Trading AG (BMP) Stock Statistics & Valuation Metrics

B.M.P. Pharma Trading AG has a market cap or net worth of EUR 33.60M. The enterprise value is ―.

Market Cap

EUR 33.60M

Enterprise Value

―

B.M.P. Pharma Trading AG has 5,250,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

5,250,000

Owned by Insiders

―

Owned by Institutions

―

B.M.P. Pharma Trading AG’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)

―

Return on Assets (ROA)

―

Return on Invested Capital (ROIC)

―

Return on Capital Employed (ROCE)

―

Revenue Per Employee

―

Profits Per Employee

-142.857

Employee Count

42

Asset Turnover

―

Inventory Turnover

―

In the last 12 months, B.M.P. Pharma Trading AG had revenue of ― and earned -6,000 in profits. Earnings per share was ―.

Revenue

―

Gross Profit

2,000

Operating Income

-642.00K

Pretax Income

―

Net Income

-6,000

EBITDA

156.00K

Earnings Per Share (EPS)

―

B.M.P. Pharma Trading AG pays an annual dividend of ―, resulting in a dividend yield of 7.81%

Dividend Per Share

―

Dividend Yield

7.81%

Payout Ratio

N/A

Free Cash Flow Yield

―

Earnings Yield

―

Beta

0.43

52-Week Price Change

21.90%

50-Day Moving Average

6.97

200-Day Moving Average

5.88

Relative Strength Index (RSI)

32.19

Average Volume (3m)

173

B.M.P. Pharma Trading AG has ― in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of ― billion.

Cash & Marketable Securities

―

Total Debt

EUR 0.00

Net Cash

―

Net Cash Per Share

―

Tangible Book Value Per Share

―

The average price target for B.M.P. Pharma Trading AG is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

91.16%

EPS Growth Forecast

17.10%